Pharmacological manipulation of sincalide (CCK-8)-induced suppression of feedingWILSON, M. C; DENSON, D; BEDFORD, J. A et al.Peptides (New York, NY. 1980). 1983, Vol 4, Num 3, pp 351-357, issn 0196-9781Article

Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramineGROPPETTI, A; PARENTI, M; DELLAVEDOVA, L et al.The Journal of pharmacology and experimental therapeutics. 1984, Vol 228, Num 2, pp 446-453, issn 0022-3565Article

SPECIES DIFFERENCES IN THE KINETICS AND METABOLISM OF FENFLURAMINE ISOMERSCACCIA S; BALLABIO M; GUISO G et al.1982; ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE; ISSN 0003-9780; BEL; DA. 1982; VOL. 258; NO 1; PP. 15-28; BIBL. 22 REF.Article

ETUDE EN DOUBLE INSU AVEC PERMUTATION CROISEE D'UNE SUBSTANCE ANOREXIGENE: LE CLOBENZOREXMIROUZE J; MARY P; LAPINSKI H et al.1973; J. MED. MONTPELLIER; FR.; DA. 1973; VOL. 8; NO 2; PP. 115-123 (5P.)Serial Issue

Fenfluramine binds 5-hydroxytryptophanSCOTT ROOT-BERNSTEIN, R; WESTALL, F. C.Brain research bulletin. 1984, Vol 12, Num 1, pp 17-22, issn 0361-9230Article

UN REEDUCATEUR DU COMPORTEMENT ALIMENTAIRE: LE CLOBENZOREX1972; REV. MED. TOULOUSE, ENSEIGN. DOCUM. INFORM.; FR.; DA. 1972; VOL. 8; NO 7; PP. 1253-1260 (5P.); BIBL. 5REF.Serial Issue

DIBOTIN (PHENFORMINE) DANS LE TRAITEMENT DE L'OBESITEMISKIEWICZ H.1972; WIADOM. LEK.; POLSKA; DA. 1972; VOL. 25; NO 21; PP. 1931-1934; ABS. RUSSE ANGL.; BIBL. 21REF.Serial Issue

TRAITEMENT DE L'OBESITE AVEC LA FENFLURAMINE. EXPERIENCES CLINIQUES ET RAPPORTS BIOCHIMIQUESGUEMES DIAZ JF.1973; VIE MED. CANADA FR.; CANADA; DA. 1973; VOL. 2; NO 3; PP. 232-245Serial Issue

FENFLURAMINE AND DERIVATIVES. PROCEEDINGS OF A SYMPOSIUM; MARBELLA, SPAIN; 19741975; POSTGRAD. MED. J., SUPPL.; G.B.; DA. 1975; VOL. 51; NO 1; PP. 1-189; BIBL. DISSEM.Conference Paper

TRAITEMENT DES FORTES OBESITES PAR LA FENFLURAMINE A FORTES DOSESSPROULE BC.1973; VIE MED. CANADA FR.; CANADA; DA. 1973; VOL. 2; NO 2; PP. 163-165Serial Issue

LE ROLE DES AGENTS ANOREXIQUES ET DES AUTRES MEDICAMENTS DANS LE TRAITEMENT DE L'OBESITELAURENT LPE.1972; VIE MED. CANADA FR.; CANADA; DA. 1972; VOL. 1; NO 5; PP. 491-493; BIBL. 2REF.Serial Issue

ANOREXIGENIC EFFECTS OF METOCLOPRAMIDE IN RATSALPHIN RS; BUCHHOLZ S; WARD JW et al.1972; EUROP. J. PHARMACOL.; NETHERL.; DA. 1972; VOL. 20; NO 2; PP. 241-242; BIBL. 6REF.Serial Issue

FACTORS INFLUENCING TOLERANCE TO D-AMPHETAMINE-INDUCED ANOREXIA IN RATSMILLOY S; GLICK SD.1976; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1976; VOL. 221; NO 1; PP. 87-95; BIBL. 10 REF.Article

FENFLURAMINE AND 5-HYDROXYTRYPTAMINE. II. INVOLVEMENT OF BRAIN 5-HYDROXYTRYPTAMINE IN THE ANORECTIC ACTIVITY OF FENFLURAMINE. = FENFLURAMINE ET 5-HYDROXYTRYPTAMINE. II. ROLE DE LA 5-HYDROXYTRYPTAMINE CEREBRALE DANS L'ACTIVITE ANOREXIGENE DE LA FENFLURAMINEDUHAULT J; BOULANGER M; VOISIN C et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 11; PP. 1758-1762; ABS. ALLEM.; BIBL. 22 REF.Article

FENFLURAMINE IN THE TREATMENT OF OBESITYSTUNKARD A; RICKELS K; HESBACHER P et al.1973; LANCET; G.B.; DA. 1973; NO 7802; PP. 503-505; BIBL. 26REF.Serial Issue

ASPECTS EPIDEMIOLOGIQUES DE LA TOXICOMANIE AUX ANOREXIGENESVAILLE C.1979; THERAPIE; FRA; DA. 1979; VOL. 34; NO 2; PP. 221-247; ABS. ENG; BIBL. 85 REF.Article

DETERMINAZIONE DELLA CONFIGURAZIONE ASSOLUTA DI COMPOSTI AMMINICI AVENTI INTERESSE FARMACEUTICO ATTRAVERSO MISURE DI DICROISMO CIRCOLARE = DETERMINATION DE LA CONFIGURATION ABSOLUE DE DERIVES AMINES, AYANT UN INTERET PHARMACEUTIQUE, AU MOYEN DU DICHROISME CIRCULAIREBETTONI G; FRANCHINI C.1976; FARMACO, ED. SCI.; ITAL.; DA. 1976; VOL. 31; NO 2; PP. 105-111; ABS. ANGL.; BIBL. 5 REF.Article

CHLORPHENTERMINE INDUCED ULTRASTRUCTURAL ALTERATIONS IN FOETAL TISSUE = ALTERATIONS ULTRASTRUCTURALES DU TISSU FOETAL INDUITES PAR LA CHLORPHENTERMINELULLMAN RAUCH R.1973; VIRCHOWS ARCH., B; DTSCH.; DA. 1973; VOL. 12; NO 4; PP. 295-302; BIBL. 8 REF.Serial Issue

ULTRASTRUCTURAL CHANGES IN ADRENAL, SPLEEN AND LIVER TISSUE, INDUCED BY CHLORPHENTERMINE = MODIFICATIONS ULTRASTRUCTURALES DES SURRENALES DE LA RATE ET DU TISSU HEPATIQUE, INDUITES PAR LA CHLORPHENTERMINELULLMANN H; LULLMANN RAUCH R; REIL GH et al.1973; KLIN. WSCHR.; DTSCH.; DA. 1973; VOL. 51; NO 6; PP. 284-285; ABS. ALLEM.; BIBL. 3 REF.Serial Issue

SPECIFICALLY DEUTERATED 1-PHENYLISOPROPYLAMINES. II. SYNTHESIS OF DEUTERIUM LABELLED PHENTERMINELINDEKE B; CHO AK; FEDORCHUK M et al.1972; ACTA PHARM. SUECICA; SUEDE; DA. 1972; VOL. 9; NO 6; PP. 605-608; BIBL. 6REF.Serial Issue

EFFICACITE DE LA FENFLURAMINE EN TANT QU'AUXILLIAIRE DU TRAITEMENT DIETETIQUE DE L'OBESITEBLONDHEIM SH; ROZEN P; SUPERSTINE E et al.1972; HAREFUAH; ISRAEL; DA. 1972; VOL. 83; NO 9; PP. 365-367; ABS. ANGL.; BIBL. 8REF.Serial Issue

Mefenorex (Rondimen®)ENGEL, J; KRISTEN, G; SCHAEFER, A et al.Drug and alcohol dependence. 1986, Vol 17, Num 2-3, pp 229-234, issn 0376-8716Conference Paper

Experimental neurotoxicity of the anorectic fenfluramine. I: A fine structural model for cerebral lysosomal storage and neuroglial reactionDASTUR, D. K; THAKKAR, B. K; DESAI, P. R et al.Acta neuropathologica. 1985, Vol 67, Num 1-2, pp 142-154, issn 0001-6322Article

Toxicomanies toxiques et intoxications: une toxicomanie méconnue: Un cas de toxicomanie à l'amineptine = Toxics toxicomanias and intoxications: an unrecognized case of toxicomania due to amineptineTREMINE, T; LAUZEL, J. P; AIGROT, S et al.Information psychiatrique. 1983, Vol 59, Num 9, pp 1185-1189, issn 0020-0204Article

Neuroleptic-like anorexia produced by an extra-cerebral DA antagonistWILLIS, G. L; SMITH, G. C; KINCHINGTON, P. C et al.Brain research bulletin. 1983, Vol 11, Num 1, pp 21-24, issn 0361-9230Article